Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Mount Sinai researchers have created an analytic tool using machine learning that can predict cardiovascular disease risk in patients with obstructive sleep apnea ...
With the integration of machine learning techniques into the medical field, there has been a sea change in the last couple of years, and a new era of innovation seems to usher in precision healthcare ...